Search

Your search keyword '"Sova, M"' showing total 247 results

Search Constraints

Start Over You searched for: Author "Sova, M" Remove constraint Author: "Sova, M"
247 results on '"Sova, M"'

Search Results

201. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

202. Limited ambulatory night sleep testing in patients with a suspicion of sleep apnoea syndrome: Is its indication tenable?

203. Reaching toward underexplored targets in antibacterial drug design.

204. Anthranilic Acid Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for Bacterial Cell Wall Biosynthesis.

205. Neurogenic pulmonary oedema as a rare complication of epileptic seizures.

206. Epicardial fat in patients with chronic obstructive pulmonary disease as a marker of high cardiovascular risk - review.

207. Pulmonary rehabilitation and oropharyngeal exercises as an adjunct therapy in obstructive sleep apnea: a randomized controlled trial.

208. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.

209. Real life adjuvant chemotherapy uptake and survival in patients with non-small cell lung cancer after complete resection.

210. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.

211. [Epicardial fat and osteoprotegerin - does a mutual relation exist? Pilot study].

212. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.

213. Possitive correlation between adipocyte fatty acid-binding protein and epicardial fat in patients with a family history of cardiovascular disesase.

214. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.

215. Discovery of new MurA inhibitors using induced-fit simulation and docking.

216. [Beta-blockers and chronic obstructive pulmonary disease].

217. Synthesis and Biological Evaluation of N-Aryl-N'-(5-(2-hydroxybenzoyl) pyrimidin-2-yl)guanidines as Toll-Like Receptor 4 Antagonists.

218. Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase.

219. Cobalt-Catalyzed Cross-Coupling of Grignards with Allylic and Vinylic Bromides: Use of Sarcosine as a Natural Ligand.

220. Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies.

221. The effect of continuous positive airway pressure therapy on the prevalence of masked hypertension in obstructive sleep apnea patients.

222. [Research of relations among sleep disorders, obstructive sleep apnoea, hypertension onset and hypertensive treatment - current or long-term trend?].

223. [Pregnancy and delivery in patients with an implanted shunt for hydrocephalus].

224. Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines.

225. [Is there dependence between the level of adipocyte fatty acid-binding protein and calcium score in asymptomatic relatives of patients with cardiovascular diseases?].

226. Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.

227. Antioxidant and antimicrobial activities of cinnamic acid derivatives.

228. Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels.

229. [The real firing wound of type of skull perforation and head penetration compared with the mathematical model of behaviour of FMJ pistol projectile of calibre of 6.35 mm Browning (25 Auto)].

230. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?

231. Complicated course of ischemic heart disease in a patient with obstructive sleep apnea.

232. [Implementation of the Amiantus project involving prophylactic medical examinations of the former employees of asbestos processing plants].

233. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?

234. Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF.

235. Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

236. Novel inhibitors of beta-ketoacyl-ACP reductase from Escherichia coli.

237. Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB).

238. Cytoplasmic steps of peptidoglycan biosynthesis.

239. New inhibitors of fungal 17beta-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold.

240. [Anterior skull base reconstruction].

241. Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study.

242. [Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000-2004].

243. Cinnamic acid esters as potent inhibitors of fungal 17beta-hydroxysteroid dehydrogenase--a model enzyme of the short-chain dehydrogenase/reductase superfamily.

244. Management of a shunt malfunction during pregnancy.

245. [Derivatives of thioallophanic acid with anthelmintic activity].

Catalog

Books, media, physical & digital resources